Death attributed to methadoneVORMFELDE, S. V; POSER, W.Pharmacopsychiatry. 2001, Vol 34, Num 6, pp 217-222, issn 0176-3679Article

The Social Phobia Psychotherapy Research Network : The First Multicenter Randomized Controlled Trial of Psychotherapy for Social Phobia: Rationale, Methods and Patient CharacteristicsLEICHSENRING, F; HOYER, J; PÖHLMANN, K et al.Psychotherapy and psychosomatics. 2009, Vol 78, Num 1, pp 35-41, issn 0033-3190, 7 p.Article

Non-response to maprotiline caused by ultra-rapid metabolism that is different from CYP2D6?VORMFELDE, S. V; BITSCH, A; MEINEKE, I et al.European journal of clinical pharmacology. 1997, Vol 52, Num 5, pp 387-390, issn 0031-6970Article

The Effects of Genetic Polymorphisms in the Organic Cation Transporters OCT1, OCT2, and OCT3 on the Renal Clearance of MetforminTZVETKOV, M. V; VORMFELDE, S. V; BALEN, D et al.Clinical pharmacology and therapeutics. 2009, Vol 86, Num 3, pp 299-306, issn 0009-9236, 8 p.Article

Interindividual Variation in the Pharmacokinetics of Δ9-Tetrahydrocannabinol as Related to Genetic Polymorphisms in CYP2C9SACHSE-SEEBOTH, C; PFEIL, J; SEHRT, D et al.Clinical pharmacology and therapeutics. 2009, Vol 85, Num 3, pp 273-276, issn 0009-9236, 4 p.Article

Genetic Variation in the Renal Sodium Transporters NKCC2, NCC, and ENaC in Relation to the Effects of Loop Diuretic DrugsVORMFELDE, S. V; SEHRT, D; TOLIAT, M. R et al.Clinical pharmacology and therapeutics. 2007, Vol 82, Num 3, pp 300-309, issn 0009-9236, 10 p.Article

Relative Impact of Genotype and Enzyme Induction on the Metabolic Capacity of CYP2C9 in HealthyVolunteersVORMFELDE, S. V; BROCKMÖLLER, J; BAUER, S et al.Clinical pharmacology and therapeutics. 2009, Vol 86, Num 1, pp 54-61, issn 0009-9236, 8 p.Article

The role of active metabolites in dihydrocodeine effectsSCHMIDT, H; VORMFELDE, S. V; WALCHNER-BONJEAN, M et al.International journal of clinical pharmacology and therapeutics. 2003, Vol 41, Num 3, pp 95-106, issn 0946-1965, 12 p.Article

Pharmacokinetics of cerivastatin in renal impairment are predicted by low serum albumin concentration rather than by low creatinine clearanceVORMFELDE, S. V; MÜCK, W; FREUDENTHALER, S. M et al.Journal of clinical pharmacology. 1999, Vol 39, Num 2, pp 147-154, issn 0091-2700Article